APA (7th ed.) Citation

R, P., MMY, W., M, M., D, B., S, B., V, C., . . . AY, W. (2025). Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community. ESC heart failure, 12(4), 2597. https://doi.org/10.1002/ehf2.15262

Chicago Style (17th ed.) Citation

R, Pecoits-Filho, et al. "Optimization of Renin-angiotensin-aldosterone Inhibitor Therapies for Evidence-based Indications: A Call to Action from the Cardio-kidney Community." ESC Heart Failure 12, no. 4 (2025): 2597. https://doi.org/10.1002/ehf2.15262.

MLA (9th ed.) Citation

R, Pecoits-Filho, et al. "Optimization of Renin-angiotensin-aldosterone Inhibitor Therapies for Evidence-based Indications: A Call to Action from the Cardio-kidney Community." ESC Heart Failure, vol. 12, no. 4, 2025, p. 2597, https://doi.org/10.1002/ehf2.15262.